Liu, Yao-Chung <br/><br/>
Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.  [electronic resource] 

 -  Japanese journal of clinical oncology  Nov 2011 
 - 1277-81 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyr140  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--genetics<br/>Carcinoma, Renal Cell--drug therapy<br/>Chromosomes, Human, X--genetics<br/>Combined Modality Therapy<br/>Female<br/>Gene Fusion<br/>Humans<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--drug therapy<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Nephrectomy<br/>Nephrotic Syndrome--chemically induced<br/>Pyrroles--therapeutic use<br/>Sunitinib<br/>Translocation, Genetic<br/>Treatment Outcome